Cold chain firm Cryoport sells specialist courier unit to DHL Group
Temperature-controlled supply chain firm Cryoport has sold its CRYOPDP business, a courier focused on clinical trials, biopharma, and cell and gene therapies, to German logistics multinational DHL Group.
In addition to the business sale, Cryoport has also confirmed a partnership with DHL to strengthen their respective offerings.
For DHL, the deal will enhance its capabilities in pharma logistics and expand its offering in the life sciences sector.
Oscar de Bok, CEO of DHL Supply Chain, described the purchase as a “pivotal move” for the company’, as it would allow the company to offer more to its pharma-specialised network.
... to continue reading you must be subscribed
Subscribe Today
To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.
